Lv2
130 积分 2022-11-18 加入
Cutaneous adverse reactions to anti–PD-1 treatment—A systematic review
1天前
已完结
Drug‐specific in vitro release of IL‐2, IL‐5, IL‐13 and IFN‐γ in patients with delayed‐type drug hypersensitivity
1天前
已完结
CD69 upregulation on T cells as an in vitro marker for delayed‐type drug hypersensitivity
1天前
已完结
Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactions
1天前
已完结
In vitrodiagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions
1天前
已完结
Delayed‐type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T‐cell reactivity study
1天前
已完结
ADVERSE DRUG REACTION MONITORING: DOING IT THE FRENCH WAY
2天前
已完结
Cutaneous adverse drug eruption: the role of drug patch testing
2天前
已完结
Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs
2天前
已关闭
Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs
2天前
已关闭
皖公网安备34019202002308
